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Abstract Activated T cells require anti-apoptotic cyto-
kines for their survival. The anti-apoptotic effects of these
factors are mediated by their inﬂuence on the balance of
expression and localisation of pro- and anti-apoptotic mem-
bers of the Bcl-2 family. Among the anti-apoptotic Bcl-2
family members, the expression level of Bcl-2 itself and its
interaction with the pro-apoptotic protein Bim are now
regarded as crucial for the regulation of survival in activated
T cells. We studied the changes in Bcl-2 levels and its
subcellular distribution in relation to mitochondrial depolar-
isation and caspase activation in survival factor deprived T
cells. Intriguingly, the total Bcl-2 level appeared to remain
stable, even after caspase 3 activation indicated entry into the
execution phase of apoptosis. However, cell fractionation
experiments showed that while the dominant nuclear pool of
Bcl-2 remained stable during apoptosis, the level of the
smaller mitochondrial pool was rapidly downregulated.
Signals induced by anti-apoptotic cytokines continuously
replenish the mitochondrial pool, but nuclear Bcl-2 is inde-
pendent of such signals. Mitochondrial Bcl-2 is lost rapidly
by a caspase independent mechanism in the absence of
survival factors, in contrast only a small proportion of the
nuclear pool of Bcl-2 is lost during the execution phase and
this loss is a caspase dependent process. We conclude that
these two intracellular pools of Bcl-2 are regulated through
different mechanisms and only the cytokine-mediated regu-
lation of the mitochondrial pool is relevant to the control of
the initiation of apoptosis.
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Introduction
In the absence of external survival signals activated T cells
enter apoptosis spontaneously. Anti-apoptotic signals
include cytokines such as Type I interferons, IL-6 and
those that signal through the common c chain (IL-2, IL-4,
IL-7, IL-15 and IL-21) [1–7]. Several lines of evidence
suggest that commitment to apoptosis under conditions of
survival signal deprivation occurs in mitochondria [8–10].
Loss of mitochondrial membrane potential is associated
with the release of pro-apoptotic factors including cyto-
chrome c. This complexes with pro-caspase 9, ATP and the
adapter protein APAF to form the apoptosome, which
cleaves and activates executioner caspases [11]. Members
of the Bcl-2 family of proteins regulate entry to apoptosis
by regulating mitochondrial membrane potential and
cytochrome c release [12–20]. This family includes pro-
apoptotic molecules such as Bax, Bad, Bak, Bim, Puma,
Noxa and Bid, and anti-apoptotic molecules, such as
Bcl-xL, A1, Mcl-1 and Bcl-2 itself, which are upregulated
by anti-apoptotic cytokines [21]. One current model sug-
gests that the main role of Bcl-2 lies in counterbalancing
the pro-apoptotic signal induced by the cooperation of Bim
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for the pro-apoptotic role of Bim involve mechanisms that
are independent of binding Bax and Bak at the mitochon-
drial level [24]. All of these models however assume a key
role for the interaction of Bim with Bcl-2. Bim and Bcl-2
appear to from stable complexes directly on the mito-
chondrial surface [25]. Loss of Bcl-2 rather than an
increase in the level of Bim levels is thought to be the
triggering process [25, 26].
Cleavage of Bcl-2 and Bcl-x by caspases during the
execution phase of apoptosis can generate cleavage prod-
ucts that facilitate apoptosis [27, 28]. Reduced transcription
of anti-apoptotic Bcl-2 family members is thought to be a
trigger for apoptosis [29–34]. However, previous reports
have suggested that the level of Bcl-2 is very stable in
murine T cells during cytokine deprivation-induced apop-
tosis [35, 36]. In these reports, the total level of Bcl-2 in
whole cell lysates was studied, but the location of Bcl-2
within the cell was not. Several groups have shown that
Bcl-2 is found in sites other than the mitochondria, with a
large proportion in the nucleus [37–40]. In the present
study, we report changes in the intracellular location of
Bcl-2 during the entry of activated T cells into apoptosis
following cytokine withdrawal. The smaller mitochondrial
pool of Bcl-2 is lost early, during commitment to apoptosis,
in a caspase independent manner. It is this mitochondrial
pool that is actively regulated by anti-apoptotic cytokines.
In contrast, the larger nuclear pool is actively cleaved by
caspases during the execution phase of apoptosis and is not
involved in the initiation of this process.
Materials and methods
T cell culture and stimulation
Non-transformed CD4
+ve T cell lines were generated by
phytohaemagglutinin (PHA) stimulation of CD4
+ve T cells
isolated by negative selection from the peripheral blood of
normal individuals as described previously [3]. T cells
were cultured in complete medium [RPMI 1640 containing
10% heat inactivated fetal calf serum, 10 mM HEPES
buffer, glutamine (2 mM), penicillin (100 U/ml), strepto-
mycin (100 lg/ml) (all Sigma, UK)] at 37 Ci na
humidiﬁed incubator with an atmosphere of 5% CO2. They
were stimulated every 14 days with 9 lg/ml PHA (PHA
HA15, Murex Biotech, Dartford, UK) and 50 U/ml
recombinant IL-2 (Chiron, Hareﬁeld, UK) in the presence
of 10% autologous EBV transformed LCL irradiated with
4,000 rads using a
60Co source (Dept. of Physics, Univer-
sity of Birmingham). T cells were maintained with
additional IL-2 (50 U/ml) every 2 days. T cell lines were
used for experimental analysis 7 days after re-stimulation
with PHA and 2 days after the last addition of IL-2. Prior to
use, T cells were subjected to ﬁcoll density centrifugation
to maximise the proportion of viable cells (Ficoll-Paque
TM
Plus, Amersham Biosciences, Uppsala, Sweden).
Cytokine deprivation induced apoptosis
T cells were cultured at a density of 1 · 10
6 cells/ml in 6,
24 or 96 well ﬂat bottomed plates in RPMI 1640 supple-
mented with 1% BSA, 10 mM HEPES buffer, glutamine
(2 mM), penicillin (100 U/ml), and streptomycin (100 lg/
ml). The kinetics of apoptosis in 6, 24 and 96 well plates
were identical (data not shown). Cells were harvested at
stated time points. In certain experiments T cells were
cultured in medium containing 50 U/ml IL-2, 10 lg/ml
cycloheximide (Sigma, UK) or 100 lM ZVAD.fmk (Cas-
pase inhibitor 1, Calbiochem).
Flow cytometric T cell survival assays
The percentage of apoptotic cells was determined by ﬂow-
cytometry following either 3,30-dihexyloxacarbocyanine
iodide (DiOC6(3)) [41] (Molecular Probes, Oregon, USA)
staining, or intracellular staining for active caspase 3, as
described below. Mitochondrial integrity was measured by a
ﬂow cytometric method based on the ability of intact mito-
chondria to take up and retain ﬂuorochromes. Cultured T
cells were loaded with 20 ng/ml DiOC6(3) for 30 min at
37 C. Cells were then washed in phosphate buffered saline
(PBS), resuspendedand analysedona Coulter Epics XL ﬂow
cytometer. The detected cells were gated on the basis of the
forward scatter and sideward scatter signal. Gated cells were
then analysed for their level of ﬂuorescence emission at
525 nm after excitiation at 488 nm, indicating accumulation
of DiOC6(3) in the intact mitochondria. The percentage of
DiOC6(3)-low cells of the total cell population analysed was
expressed as % apoptotic cells. The staining was compared
with staining with JC-1 (Molecular Probes) and yielded
identical results in split samples (data not shown). For the
ﬂow cytometric analysis of caspase 3 activation, T cells were
ﬁxed and permeabilised using PermeaFix
TM solution (Ortho
Diagnostic Systems Inc., New Jersey, USA) for 45 min at
roomtemperature.TheﬁxedcellswerewashedtwiceinPBS,
before incubation in 50% fetal calf serum in RPMI to reduce
non-speciﬁc antibody binding. Cells were then stained with
an afﬁnity puriﬁed rabbit anti-active caspase 3 antibody (BD
PharMingen, California, USA) or normal rabbit immuno-
globulin fraction (Dako, Denmark) as a negative control.
These were detected with ﬂuorescein (FITC) labelled goat
anti-rabbit IgG antiserum (Southern Biotech, Birmingham,
AL, USA).
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membrane potential and Bcl-2
T cells were incubated with 50 nM MitoTracker Red
CMXRos (Molecular Probes, Oregon, USA) for 30 min at
37 C, washed once in 2% bovine serum albumin (BSA)
(Sigma, UK) in PBS, resuspended in 2% BSA in PBS and
transferred onto a glass slide in a cytocentrifuge (Shandon,
USA). Cells were ﬁxed and permeabilised in acetone
(Fisher Scientiﬁc UK Ltd, UK). Blocking was performed
with 20% goat serum (Dako, Denmark), 0.2% ﬁsh skin
gelatin (Sigma, UK), 0.5% casein (Fisher Scientiﬁc UK
Ltd, UK) in PBS for 60 min. Monoclonal mouse anti-
human Bcl-2 antibody, clone 124, (Dako, Denmark) or
mouse IgG1 negative control (Dako, Denmark) were
applied for 60 min followed by 2 washes with PBS. Biotin
conjugated goat anti-mouse IgG was applied for 30 min
followed by 2 washes with PBS. Primary and secondary
antibodies were diluted in 20% goat serum, 0.2% ﬁsh skin
gelatin, 0.5% casein in PBS. FITC-conjugated streptavidin
(Dako, Denmark) was applied for 30 min followed by 2
washes with PBS. The nuclei, were counterstained with
40,6-diamidino-2-phenylindole dihydrochloride (DAPI) at
40 ng/ml. Samples were mounted (AF1, Citiﬂuor Ltd., UK)
and visualised using a confocal immunoﬂuorescence
microscope (Zeiss LSM 510 based on a Zeiss Axiophot
M100). A 63· water immersion lens was used and a 2·
zoom added in the Zeiss LSM software. The images were
processed in PaintShop pro version 5 to enhance contrast
and brightness.
Caspase-3 activity assay
Cell pellets were made at appropriate time points and
frozen in liquid nitrogen. Cells were thawed, resuspended
in modiﬁed hypotonic cell lysis buffer (25 mM HEPES pH
7.5, 5 mM MgCl2, 2 mM PMSF, 10 lg/ml Pepstatin A,
10 lg/ml AEBSF 2 mM, EDTA 1 mM, Bestatin 130 lM,
E-64 14 lM, Leupeptin 1 lM, Aprotinin 0.3 lM (Sigma,
UK)) and lysed by taking them through 3 freeze thaw
cycles. Samples were centrifuged at 16,000g at 4 C for
20 min and the supernatant removed. Protein quantiﬁcation
was performed using the bicinchoninic acid (BCA) protein
assay kit (Pierce Chemical Company, USA) according to
manufacturer’s instructions. The level of protein in each
sample was standardised by adding appropriate amounts of
modiﬁed lysis buffer (5 mM DTT and 5 mM EDTA).
Caspase 3 activity was measured with the CaspACE
TM
ﬂuorimetric assay system (Promega, Wisconsin, USA)
according to manufacturer’s instructions using the ﬂuo-
rescent labelled caspase 3 substrate ac-DEVD-AMC on a
Perkin-Elmer ﬂuorimeter with Ascent ﬂuoroscan software.
3H leucine protein synthesis assay
T cells were incubated in ﬂat bottomed 96 well plates in the
presence of 0.4 lCi
3H leucine (Amersham, UK) in a total
volume of 100 ll. At appropriate time points, 100 llo f
10% trichloroacetic acid (w/v) (Fisher Scientiﬁc UK Ltd.,
UK) was added and the cells incubated on ice for 1 h. Cells
were harvested onto ﬁlter paper and the radioactivity
measured using a beta plate reader.
Cell fractionation
Cells were incubated in hypotonic swelling buffer (20 mM
Tris pH 7.4, 2 mM MgCl2, 5 mM EDTA, 1 mM Sodium
Vanadate, 10 lg/ml each of pepstatin, leupeptin and
aprotinin and 2 mM AEBSF) for 30 min. This was fol-
lowed by homogenisation with a Dounce homogenizer.
Cellular disruption was controlled by microscopic obser-
vation of Trypan blue stained cells. The homogenate was
fractionated by centrifugation for 1,000g for 4 min
(nuclei), 10 min for 10,000g (mitochondria, heavy mem-
branes), and 30 min at 100,000g (to separate the cytosol
from the plasma membrane and light membrane fraction).
The nuclear, mitochondrial and plasma membrane pellets
were resuspended in SDS PAGE sample buffer. The
cytosolic fraction was mixed with 0.1 Vol 10· SDS PAGE
buffer. Samples were heated for 5 min at 95 C and stored
for western blotting.
Western blotting
For the majority of experiments western blots samples
were loaded on a cell equivalent basis. In the experiments
shown in Figs. 1b and 2a, 5 · 10
6 T cells were lysed in
SDS PAGE sample buffer and heated for 5 min to 95 C.
The equivalent of 0.5 · 10
6 cells per lane were loaded on
SDS-PAGE gels. For the experiments shown in Figs. 3a, 4a
and 5,2 0· 10
6 cells per sample were fractionated and the
equivalent of the nuclear, mitochondrial cytosolic and
membraneous content of 2 · 10
6 cells were loaded onto
western blots per lane. For the experiments shown in
Fig. 3b the SDS-PAGE gels were loaded with equal protein
amounts. For this purpose, the cell pellets of the mito-
chondrial fractions were resuspend in lysis buffer
containing 0.26 M Tris pH6.8, 2.6% SDS and 1% protease
inhibitor cocktail (Sigma, St Louis, MO, USA). The protein
concentration was assayed using the BCA assay according
to the manufacturer’s instructions (Pierce, Rockford, IL,
USA).BSAinarangeofconcentrationsfrom4–0.003 mg/ml
in lysis buffer was used as a standard. After protein
quantiﬁcation 27 ll of a solution containing 80% Glycerol
Apoptosis (2008) 13:109–117 111
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were added per 100 ll lysate. Samples were heated for
5 min at 95 C. 5 lg protein was loaded onto SDS-PAGE
gels per lane. Total cellular proteins separated by SDS-
PAGE and transferred to PVDF membrane (Flowgen)
using a wet blotting system (Bio rad). Blots were blocked
in 4% nonfat milk powder and probed with antibodies to
caspase 3 (Rabbit anti-caspase 3, Pharmingen), Bcl-2 (BD
Pharmingen) or Actin (Sigma) or VDAC-1 (Abcam,
Cambridge, UK).
Results
Activated T cells rapidly enter apoptosis if deprived of
survival-inducing cytokines.
As shown in Fig. 1a, our experimental conditions
allowed a rapid and reproducible initiation of apoptosis in
CD4
+ve activated T cells following survival factor depri-
vation. We analysed the time course of activation of
caspase 3 in relation to the changes of Bcl-2 expression in
this experimental system by western blotting (Fig. 1b). In
parallel experiments mitochondrial depolarisation and
caspase 3 activation were assessed by ﬂow cytometry
(Fig. 1a). Activation of caspase 3 and mitochondrial
depolarisation showed a maximal rate of change between
4 h and 12 h. This corresponded well with the appearance
of the cleaved form of caspase 3 and loss of the pro-form
of caspase 3. The active fragment of caspase 3 was
detected as a faint band at 4 h and as a strong band at
8 h. Members of the Bcl-2 family are thought to regulate
T cell apoptosis at the mitochondrial level. Induction of
expression of Bcl-2 by cytokines signalling through the
shared c-chain of the IL-2 receptor is an important reg-
ulator of T cell survival. The changes in Bcl-2 expression
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Fig. 1 Kinetics of caspase 3 activation, mitochondrial depolarisation
and Bcl-2 levels in survival factor deprived activated T cells. (a)
Activated T cells were cultured in the absence of survival factors for
0, 4, 6,12, 24 and 48 h. At these time points cells were stained with an
antibody speciﬁc for activated caspase 3 (closed symbols). The
fraction of cells with low mitochondrial membrane potential was
measured by staining with DiOC6(3) (open symbols). The data shown
represent the mean and SD of 4 independent experiments. (b)
Changes in the levels of expression of proteins regulating apoptosis in
T cells deprived of survival factors were determined by western
blotting. Activated T cells were cultured in the absence of survival
factors for 0, 2, 4, 8, 12 and 24 h. The cells were lysed and subjected
to western blotting analysis for Bcl-2 and caspase 3. Blots for actin
were run to control for equal loading. Activation of caspase 3 occurs
early in cytokine deprivation mediated apoptosis of T cells, while
Bcl-2 levels appeared to remain stable throughout the experiment.
The 21 kD cleavage product of Bcl-2 was detected concurrently with
the activation of caspase 3. The experiment shown is one represen-
tative of 3 independent experiments performed
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Fig. 2 The inﬂuence of caspase activity on the level of Bcl-2 in T
cells deprived of survival factors. (a) Activated T cells were cultured
for 12, 24 and 48 h in the presence and absence of ZVAD.fmk, an
irreversible broad range inhibitor of caspases. Cells were lysed and
analysed for the loss of whole length Bcl-2 and the appearance of the
21 kD cleaved form by western blotting. Blots were also probed for
actin to control for equal cell input. The appearance of the cleaved
21 kD form of Bcl-2 was inhibited by ZVAD.fmk. (b) Activated T
cells were cultured for 6, 12, 24 and 48 h in the presence (closed bars)
and absence (empty bars) of ZVAD.fmk, an irreversible broad range
inhibitor of caspases. The inhibition of caspase activity led to a minor
and transient delay of mitochondrial depolarisation. The percentage of
cells with depolarised mitochondria was determined by staining cells
with DiOC6(3) and measurement of the fraction of cell population
able to retain this dye (3). (c) The efﬁciency of ZVAD.fmk-mediated
inhibition of caspase 3 in this cellular system was determined by
measure of the enzymatic activity of caspase 3 in an assay measuring
the cleavage of a ﬂuorogenic substrate in cells cultured without
(empty bars) or with ZVAD.fmk (ﬁlled bars). Activity of caspase 3
was reliably inhibited by ZVAD.fmk. The results shown here are
means and SD of triplicates of one experiment representative for 3
independent similar experiments performed
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123following survival factor withdrawal were investigated by
western blotting. Intriguingly, whilst low levels of the
cleavage product of Bcl-2 were detectable after 8 h, levels
of intact Bcl-2 remained largely unchanged over time.
These experiments suggested that a signiﬁcant loss of
Bcl-2 did not precede mitochondrial depolarization and
caspase 3 activation.
The caspase inhibitor ZVAD.fmk was used to test if the
appearance of the short form of Bcl-2 was caspase-
dependent. As shown in Fig. 2a the appearance of the short
form of Bcl-2, within 12 h of cytokine withdrawal, was
efﬁciently blocked by the caspase inhibitor. Loss of the
full-length form of Bcl-2 was only apparent at the latest
time point (48 h) and the caspase inhibitor had little effect
on this. The effect of the caspase inhibitor on mitochon-
drial depolarisation is shown in Fig. 2b. There was a minor
delay of mitochondrial depolarisation at the earlier time
points, but by 48 h no effect of caspase inhibition on
mitochondrial depolarisation was observed. The efﬁciency
of caspase 3 inhibition under these culture conditions was
tested by assessing the enzymatic activity of caspase 3 in
lysates of the T cells. Figure 2c shows that at all time
points investigated, ZVAD.fmk effectively blocked cas-
pase 3 activation. These data are consistent with a model of
T cell apoptosis in which detectable loss of overall Bcl-2
does not play a key role in the regulation of mitochondrial
integrity, because it is lost only after mitochondrial depo-
larisation has taken place. At this stage the cells have fully
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Fig. 3 Inﬂuence of cytokine deprivation on the subcellular localisa-
tion of Bcl-2. (a) Activated T cells were cultured in the absence of
survival factors for 0, 6, 12 and 24 h. The cells were fractionated into
nuclear, mitochondrial, cytoplasmic and plasma membrane fractions
by centrifugation and equivalents of fractions derived from 2 · 10
6
cells per lane were probed for Bcl-2 by western blotting. The
cytoplasmic fractions were probed for actin to control for equal cell
input. The largest fraction of Bcl-2 was found to be localised in the
nuclei. Most of the remaining Bcl-2 was detected in the mitochondrial
fraction, and a very small amount in the plasma membrane fraction.
While the nuclear fraction remained stable throughout the experi-
ment, there was a continuous loss of Bcl-2 from the mitochondrial
fraction, which was evident from the 6 h time point. One experiment
shown as representative of 3 similar experiments performed. (b)T o
control if these changes in Bcl-2 levels were speciﬁc for mitochondria
and not caused by general loss of mitochondrial protein, these
experiments were repeated with 5 lg protein per lane. Loading
controls used here were speciﬁc for mitochondria (VDAC-1). (c)
Activated T cells were cultured in the absence of survival factors for
0, 6, 12 and 24 h. 20 min before harvesting, the live cells were
incubated in Mitotracker CR red
TM to label mitochondria with an
intact mitochondrial membrane potential red. Cells were then spun
onto slides using a cytospin centrifuge and stained for Bcl-2 (green).
Analysis by confocal microscopy revealed staining for Bcl-2 both on
the mitochondria as well as on the nuclear envelope at time 0. At 6 h
and at the later time points the mitochondrial staining was found to be
less intense, while the nuclear staining remained stable. Images
shown here are representative of 4 independent experiments
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123activated caspase 3 and have entered the execution phase of
apoptosis.
The anti-apoptotic role of Bcl-2 may be restricted to
speciﬁc sites within the cell. To test this hypothesis, T cells
were fractionated by centrifugation at different g/forces
into the nuclear, cytosolic, light membrane and heavy
membrane fractions. The heavy membrane fraction
contained most of the mitochondrial membrane, while the
light membrane fractions contained the plasma membrane.
The efﬁciency of fractionation was tested by western blot
detection of marker proteins characteristic of the respective
fractions. Lamin B, a constituent of the nuclear envelope
was exclusively found in the nuclear fraction. Actin was
found in the cytosolic fraction, and TIM 23 a mitochondrial
membrane transporter protein was detected in the heavy
membrane, or mitochondrial fraction. Pan-cadherin, a
molecule expressed on the plasma membrane was found in
the light membrane fraction (data not shown). The majority
of the cellular Bcl-2 was detected in the nuclear fraction
(ca. 60%, by densitometric analysis of western blots). The
mitochondrial fraction contained about 30% of the cellular
Bcl-2 and a minor amount was detected in the cytosolic
fraction. In the experiment shown in Fig. 3a, T cells were
fractionated after deprivation of survival factors. Intrigu-
ingly, the cleaved fragment of Bcl-2 was only detected in
the nuclear fraction, a consistent ﬁnding throughout all
fractionation experiments performed in this study. This
cleavage product appears to be very susceptible to prote-
olytic degradation as it appeared as a single band in the
experiments in which we directly lysed the cell pellets in
SDS-PAGE running buffer, while multiple bands became
apparent in the samples after the fractionation process.
A striking observation was that while the level of full
length nuclear Bcl-2 remained stable for the duration of the
experiment, the level of mitochondrial Bcl-2 decreased at
an early stage following cytokine deprivation. This loss of
Bcl-2 from the mitochondrial fraction was clearly seen as
early as 6 h and therefore coincided with the sharp increase
in mitochondrial depolarisation and caspase 3 activation.
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IL-2 and cycloheximide. Cells were fractionated and mitochondrial
and nuclear fractions were probed for Bcl-2 by western blotting. The
cytoplasmic fractions were probed for actin to control for equal cell
input. The experiment shown is one representative of 3 independent
experiments performed. (b) The effect of cycloheximide on T cell
apoptosis in this experimental system was determined by measuring
the percentage of cells with activated caspase 3 in samples taken from
the cultures used for the fractionation experiments. Clear bars indicate
cells cultured in medium alone, upwards hatched bars cells cultured
with IL-2, downwards hatched bars cells cultured with cycloheximide
and ﬁlled bars indicate cells cultured in both cycloheximide and IL-2.
The results shown here represent the mean and SD of three
experiments performed. (c) The efﬁciency of cycloheximide mediated
inhibition of protein synthesis in this cellular system was determined
by measuring the incorporation of
3H leucine. Clear bars indicate cells
cultured in medium alone, upwards hatched bars cells cultured with
IL-2, downwards hatched bars cells cultured with cycloheximide and
ﬁlled bars indicate cells cultured in both cycloheximide and IL-2. The
results shown here are means and SD of triplicates representative for
three experiments performed
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Fig. 5 The role of caspase activity in the regulation of Bcl-2 levels in
nuclei and mitochondria. To answer the question if loss of Bcl-2 from
the mitochondria or nuclear pool was upstream or downstream of
caspase activation, we incubated T cells in the presence and absence
of ZVAD.fmk for 12, 24 and 48 h, fractionated them and probed the
nuclear and mitochondrial fractions for Bcl-2. The cytoplasmic
fractions were probed for actin to control for equal cell input. While
the levels of full length Bcl-2 in the nuclear fraction were not
obviously affected within the time frame of the experiment, the
appearance of the cleaved 21 kD fragment of Bcl-2 was blocked by
ZVAD.fmk. The loss of Bcl-2 from the mitochondrial fraction was
not affected by ZVAD.fmk, suggesting that this is an event that
occurs upstream of caspase activation. The experiment shown is one
representative of 3 independent experiments performed
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123These observations suggest that while no obvious change
occurred in the total level of Bcl-2 within the cell (Fig. 1b)
there was an early loss of Bcl-2 from the mitochondrial
fraction, which was masked by the stability of the larger
nuclear pool. While the SDS-PAGE gels had been loaded
on the basis of cell equivalents in the initial experiments,
we repeated the experiment by loading equal amounts of
protein. We used an antibody to the Voltage Dependent
Anion Channel (VDAC-1), which is localised in the outer
mitochondrial membrane, control for equal loading of
mitochondrial proteins. The result of these experiments is
shown in Fig. 3b. The loss of Bcl-2 from the mitochondrial
fraction, is again apparent under these conditions. Presence
of IL-2 in the cultures counteracted the loss of Bcl-2 from
the mitochondria.
Similar results were obtained using immunoﬂuorescence
(Fig. 3c). Initially, Bcl-2 was seen on the nuclear envelope
and the mitochondria. By 6 h, loss of Bcl-2 from the
mitochondria was observed, but staining of the nuclear
envelope remained stable.
These data suggest that two separate pools of Bcl-2 in T
cells are regulated at different stages of apoptosis.
The mechanism of this regulation was investigated in
subsequent experiments. Mitochondrial Bcl-2 appeared to
be less stable than that in the nuclear pool. To test whether
the mitochondrial pool was more dependent on continuous
synthesis of Bcl-2 than the nuclear fraction, T cells were
cultured in the presence of IL-2 and cycloheximide. Cell
fractionation experiments showed that Bcl-2 in the nuclear
fraction remained stable under all conditions tested in the
experiments, but that the mitochondrial fraction maintained
stable Bcl-2 levels only in the presence of IL-2 and the
absence of cycloheximide (Fig. 4a). These results suggest
that the mitochondrial pool of Bcl-2 depends upon constant
replenishment by induction of de novo synthesis of Bcl-2
by anti-apoptotic cytokines. However, the stable Bcl-2
expression in the nucleus was independent of protein
synthesis over the time period studied. While cyclohexi-
mide did inhibit the survival effect of IL-2 it did not appear
to have an added toxic effect above that of IL-2 deprivation
within these experiments (Fig. 4b), but protein synthesis
was effectively inhibited (Fig. 4c).
These data indicate that the mitochondrial pool of Bcl-2
is critically dependent on anti-apoptotic cytokines in the
microenvironment and support a role for mitochondrial
Bcl-2 in the regulation of T cell apoptosis by cytokines.
The caspase dependent cleavage fragment of Bcl-2 was
restricted to the nuclear fraction (Fig. 3a). This suggested
that only the loss of nuclear Bcl-2 was mediated by caspase
dependent cleavage. T cells were incubated with
ZVAD.fmk and fractionated at speciﬁc time points. The
short form of Bcl-2 was absent from the samples treated
with ZVAD.fmk, but the loss from the mitochondrial
fraction was unaffected by inhibition of caspases (Fig. 5).
These data suggest that the loss of mitochondrial Bcl-2 is
caspase independent. Therefore we conclude that the two
intracellular pools of Bcl-2 are regulated by at least two
different mechanisms at different stages in the apoptotic
pathway.
Discussion
During the resolution of an immune response, loss of
extracellular survival signals leads to a dramatic reduction
in activated T cell numbers by apoptosis. Mitochondria are
widely regarded as the regulators of this apoptotic pathway
[8–10]. Their role in apoptosis is controlled by pro- and
anti-apoptotic proteins of the Bcl-2 family [12–20]. Many
anti-apoptotic cytokines upregulate the transcription of
genes for anti-apoptotic Bcl-2 family members [2]. In the
absence of these survival signals, activated T cells are
programmed to enter apoptosis. There is very strong evi-
dence suggesting a role for Bcl-2 itself in the regulation of
T cell apoptosis [2, 42, 43]. However, Broome et al. have
shown that Bcl-2 levels remain stable after the induction of
apoptosis in activated murine T cells and are not down-
regulated even late in apoptosis [35, 36]. Our data brings
these observations together by demonstrating two spatially
distinct pools of Bcl-2 within T cells that are differentially
regulated and are lost at different stages of apoptosis
through distinct mechanisms. The survival signal IL-2
maintains mitochondrial Bcl-2 levels in a translationally
dependent manner. Withdrawal of IL-2 leads to loss of
mitochondrial Bcl-2. This loss is independent of caspase
activation. In contrast, the larger nuclear pool remains
stable until caspase 3 is fully activated and a small pro-
portion is then cleaved in a caspase-dependent manner. If
only the total cellular levels of Bcl-2 are assayed, the sta-
bility of the larger nuclear pool can mask the loss of the
smaller mitochondrial pool at an early stage of apoptosis.
We conclude from these observations that only the smaller
cytokine-regulated mitochondrial pool of Bcl-2 is relevant
to the initiation of the apoptotic pathway and that mea-
suring the total cellular level of Bcl-2 is less informative.
Bcl-2 degradation has been shown to be caused by tar-
geting of Bcl-2 to the protesomal system by
ubiquitinylation [44]. Ubiquitinylation appears to be reg-
ulated by at least two mechanisms. Phosphorylation of Bcl-
2 at MAPK target sites protects it from ubiquitinylation and
subsequent degradation [45]. In a more recent report
endothelial nitric oxide synthase, which is also expressed
by T cells, was shown to generate nitric oxide which
S-nitrosylates Bcl-2 and prevents its ubiquitinylation
[46, 47]. It is not clear which of these mechanisms plays a
dominant role in the regulation of Bcl-2 levels in T cells,
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less accessible to ubiquitinylation or one of the mecha-
nisms regulating it.
Bcl-2 is known to be a target for caspase 3. Intriguingly,
we only found the caspase dependent cleaved fragment of
Bcl-2 in the nuclear fraction. The majority of active cas-
pase 3 is cytosolic [11], and Bcl-2 is localised on the leaﬂet
of the mitochondrial membrane facing the cytosol [39]s oi t
was surprising that no cleaved Bcl-2 was detected in the
cytosol or the mitochondria. This may reﬂect highly efﬁ-
cient degradation of mitochondrial Bcl-2 before caspase 3
activation. The cleaved fragment of Bcl-2 has been
reported to have a pro-apoptotic function [28]. If trans-
fected into cells, it localises to the mitochondria and forms
ion channel like structures that mediate cytochrome c
release [28]. However, the role of this potentially pro-
apoptotic Bcl-2 fragments in spontaneous T cell apoptosis
has not been previously addressed. In the present study, the
generation of the cleaved fragment was entirely dependent
upon caspase activation and no cleaved Bcl-2 was detect-
able in the mitochondrial fraction. This data does not
support the contention that cleaved Bcl-2 controls mito-
chondrial polarity during the initiation of spontaneous
apoptosis [28].
While it is difﬁcult to assess the functional signiﬁcance
of a stable nuclear pool of Bcl-2, a tightly controlled
mitochondrial pool is likely to be necessary for the regu-
lation of mitochondrial stability and the apoptotic pathway.
The role of Bcl-2 on the nuclear envelope and the function
of the cleaved fragment at this site during the execution
phase of apoptosis remain unclear. Nuclear Bcl-2 may
mediate the anti-proliferative effects associated with this
protein [48]. Such a role would ﬁt with its stability in the
early stages of apoptosis. During the execution phase of
apoptosis nuclear Bcl-2 is cleaved in a caspase-dependant
manner to the pro-apoptotic form. It is therefore possible
that in the nucleus, the cleaved fragment of Bcl-2 plays a
role in the later phases of the apoptotic pathway, but not in
regulating entry to apoptosis. Bim, a pro-apoptotic member
of the Bcl-2 family has recently been shown to be involved
in the initiation of survival factor deprivation induced
apoptosis [49]. Even though Bim can bind to components
of the dynein motor system, in T cells most of the cellular
Bim is bound to the mitochondria, where it directly inter-
acts with Bcl-2 [25]. The pro-apoptotic effect of Bim in T
cells can be balanced by over-expression of Bcl-2 [49].
These data support the previously described anti-apoptotic
effect of Bcl-2 in the regulation of T cell numbers in vivo.
Bcl-2 deﬁcient mice are severely lymphopenic and their
lymphocytes show increased susceptibility to apoptosis
[30–33]. Over-expression of Bcl-2 under the vav-promotor
results in increased T cell numbers [50]. The regulation of
T cell survival by anti-apoptotic cytokines is fundamental
in maintaining T cell numbers during inﬂammatory
responses and in restoring a homeostatic balance during the
resolution of inﬂammation. Dysregulation of this process
contributes to the pathology of diseases such as rheumatoid
arthritis.
Conclusion
We have characterised the regulation of Bcl-2 levels in T
cell apoptosis induced by cytokine withdrawal. The mito-
chondrial pool of Bcl-2 is modulated prior to the
commitment to apoptosis, while the nuclear pool remains
stable. Only the mitochondrial pool is regulated by the
presence of anti-apoptotic cytokines. Consequently, we
suggest that the role of anti-apoptotic cytokines in inhib-
iting T cell apoptosis by Bcl-2 induction is limited to the
up-regulation of the mitochondrial pool of Bcl-2.
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